Displaying drugs 301 - 325 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Protein C | Not Available |  | A medication used to treat protein C deficiency leading to purpura fulminans or coumarin-induced skin necrosis. | Enzymes |
| Protein S human | 75123.0 |  | A medication used for emergency reversal of coagulation factor deficiency in vitamin K antagonist therapy. | Anticoagulants / Blood Coagulation Factor Inhibitors / Blood Proteins / Glycoproteins |
| Prothrombin | Not Available |  | A coagulation factor used for emergency reversal of vitamin K antagonist therapy. | Blood Coagulation Factors / Enzyme Precursors / Prothrombin, agonists |
| Pucotenlimab | Not Annotated | | Pucotenlimab is a recombinant humanized anti-PD-1 monoclonal antibody. It received its first global approval in China in July 2022 for the treatment of solid tumours. It is being investigated in... | Not Annotated |
| Rabies immune globulin, human | Not Available | | A solution of antibodies used to prevent rabies after an exposure. | Human Rabies Immune Globulins / Serum / Vaccines |
| Ramucirumab | 143600.0 C6374H9864N1692O1996S46 |  | An antineoplastic agent and direct VEGFR2 (vascular endothelial growth factor receptor 2) antagonist that blocks the binding of natural VEGF ligands, which are secreted by solid tumors to promote angiogenesis and enhance tumor blood supply. | Angiogenesis Inhibitors / Antibodies, Monoclonal / VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors |
| Ranibizumab | 48349.6111 C2158H3282N562O681S12 |  | A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. | Antineovascularisation Agents |
| Rasburicase | 34109.5 C1521H2381N417O461S7 |  | A recombinant form of urate-oxidase enzyme used to treat hyperuricemia following chemotherapy for leukemias and non-Hodgkin's lymphoma. | Detoxifying Agents for Antineoplastic Treatment |
| Ravulizumab | 148000.0 C6430H9888N1696O2028S48 | | A monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. | Selective Immunosuppressants |
| Raxibacumab | 142844.5367 C6320H9794N1702O1998S42 |  | A monoclonal antibody used in conjunction with an antibacterial regimen to treat patients with inhalational anthrax caused by Bacillus anthracis and for prophylaxis of inhalational anthrax when appropriate. | Antibacterial monoclonal antibodies / Specific Immunoglobulins |
| Recombinant Cholera Toxin B Subunit | Not Annotated | | Recombinant Cholera Toxin B Subunit is an ingredient in the EMA-authorised product Dukoral. | Adjuvants, Immunologic / ADP Ribose Transferases / Bacterial Toxins / Cholera Toxin / Enterotoxins / Poisons |
| Regdanvimab | Not Available | | A monoclonal antibody targeted against the SARS-CoV-2 spike protein used to treat patients with COVID-19 who are at risk of progressing to severe COVID-19. | Antiviral monoclonal antibodies |
| Relatlimab | 148000.0 C6472H9940O2026N1704S38 | | A monoclonal antibody targeted against LAG-3 which is used in combination with nivolumab for the treatment of unresectable or metastatic melanoma. | Immune Checkpoint Inhibitors |
| Reslizumab | 147000.0 |  | An IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults. | Anti-Asthmatic Agents / Interleukin-5 Antagonist |
| Reteplase | 39589.6 C1736H2671N499O522S22 |  | A purified form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli. | Enzymes |
| Retifanlimab | 148000.0 C6456H9934N1702O2032S46 | | A PD-1–blocking antibody indicated for the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma. | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| rhThrombin | Not Annotated | | Investigated for use/treatment in blood (blood forming organ disorders, unspecified) and hemorrhage. | Not Annotated |
| Rilonacept | 251000.0 C9030H13932N2400O2670S74 | | An IL-1 inhibitor used to treat cryopyrin-associated periodic syndrome, a rare hereditary inflammatory disorder. | Interleukin Inhibitors |
| Risankizumab | 149000.0 C6476H9992N1720O2016S44 | | An interleukin-23 antagonist used to treat plaque psoriasis, psoriatic arthritis, and Crohn's disease in adults. | Interleukin Inhibitors |
| Rituximab | 143859.7 C6416H9874N1688O1987S44 |  | A monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis. | Antibodies, Monoclonal / CD20 (Clusters of Differentiation 20) inhibitors |
| Romiplostim | 59000.0 C2634H4086N722O790S18 | | A fusion protein thrombopoietin (TPO) peptide analog that increases platelet counts by binding to and activating the human TPO receptor. Used to treat thrombocytopenia associated with chronic immune thrombocytopenia (ITP). | Receptors, Thrombopoietin, agonists / Thrombopoietin Receptor Agonist |
| Romosozumab | 145805.0 | | A monoclonal antibody used to treat osteoporosis in postmenopausal women at high risk of fracture, patients who are intolerant of other treatments, or patients who have failed other treatments. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Blood Proteins / Bone Anabolic Agents / Drugs Affecting Bone Structure and Mineralization / Drugs for Treatment of Bone Diseases / Globulins / Immunoglobulins / Immunoproteins / Musculo-Skeletal System / Proteins / Sclerostin Inhibitors / Serum Globulins |
| Ropeginterferon alfa-2b | 60000.0 C16H29N3O6(C2H4O)n(C2H4O)n |  | A mono-pegylated type I interferon used to treat polycythemia vera. | Interferons |
| Rozanolixizumab | 148000.0 | | A humanized monoclonal antibody targeting the human neonatal Fc receptor (FcRn) used to treat generalized myasthenia gravis. | Immunosuppressive Agents |
| Rurioctocog alfa pegol | 269812.0 C12257H17863N3220O3552S83 | | A pegylated recombinant human coagulation factor VIII used to treat and prevent bleeding episodes in patients 12 years and above with hemophilia A. | Coagulants / Recombinant Proteins |
Displaying drugs 301 - 325 of 406 in total